BTW, by "can fund 150 experimental drugs", don't count on it being your favorite company conducting advanced clinical trials. I think he's looking at much earlier stages than that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.